Attached files

file filename
10-Q - QUARTERLY REPORT - TG THERAPEUTICS, INC.v231763_10q.htm
EX-31.1 - EXHIBIT 31.1 - TG THERAPEUTICS, INC.v231763_ex31-1.htm
EXHIBIT 32.1
 
CERTIFICATIONS
OF
 PRINCIPAL EXECUTIVE OFFICER
 
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Manhattan Pharmaceuticals, Inc. does hereby certify that, to the best of his knowledge:
                  (a)      the Quarterly Report on Form 10-Q of Manhattan Pharmaceuticals, Inc. for the quarter ended June 30, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
                  (b)      information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Manhattan Pharmaceuticals, Inc.
 
Dated: August 15, 2011
  /s/ Michael G. McGuinness
 
 
Michael G. McGuinness
 
 
Principal Executive and Financial Officer